机译:PRMT5作为胶质母细胞瘤治疗的可治疗靶标
Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Vivian L Smith Dept Neurosurg, Houston, TX 77030 USA;
Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA;
Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA;
Univ Florida, Coll Pharm, Dept Med Chem, Gainesville, FL USA;
Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA;
Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA;
Ohio State Univ, Coll Med, Dept Neurol, Lab Neural Stem Cells & Funct Neurogenet,Div Neur, Columbus, OH 43210 USA;
Univ Florida, Coll Pharm, Dept Med Chem, Gainesville, FL USA;
Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Vivian L Smith Dept Neurosurg, Houston, TX 77030 USA;
Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USA;
Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USA;
Ohio State Univ, Dept Biomed Informat, Ctr Biostat, Columbus, OH 43210 USA;
Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA;
Ohio State Univ, Dept Internal Med, Div Hematol, Coll Med, Columbus, OH 43210 USA;
Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Vivian L Smith Dept Neurosurg, Houston, TX 77030 USA;
CMP5; GBM; glioma; PRMT5; senescence;
机译:蛋白质精氨酸甲基转移酶PRMT5作为胶质母细胞瘤候选治疗靶标的遗传验证
机译:从双靶向小纳米粒子的按需药物释放,由高强度聚焦超声增强的胶质母细胞瘤靶向治疗引发
机译:PIML001,一种端粒靶向药物,通过DNA损伤和细胞凋亡使胶质母细胞瘤细胞敏感到替莫唑胺化学疗法和放射疗法
机译:纳米药物联合药物和基因疗法治疗胶质母细胞瘤
机译:合成纳米低密度脂蛋白作为多形性胶质母细胞瘤的靶向药物递送载体
机译:PRMT5作为胶质母细胞瘤治疗的可治疗靶标
机译:exth-26。 PRMT5作为胶质母细胞瘤治疗的可耐药靶标